Forte Biosciences, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Forte Biosciences, Inc. reported Cash And Cash Equivalents At Carrying Value of $76.96 million for the year ending 2025.

  • Forte Biosciences, Inc. showed an increase of +246.0% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Forte Biosciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
  • XBRL data for this metric is available from 2014 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 12 years of available data (2014 to 2025), Forte Biosciences, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 1,730.6%.
  • Historical annual values: Fiscal year 2025: $76.96 million | Fiscal year 2024: $22.24 million | Fiscal year 2023: $37.13 million | Fiscal year 2022: $41.10 million | Fiscal year 2021: $42.04 million | Fiscal year 2020: $58.77 million | Fiscal year 2019: $6.94 million | Fiscal year 2018: $40.81 million | Fiscal year 2017: $35.93 million | Fiscal year 2016: $5.51 million | Fiscal year 2015: $8.15 million | Fiscal year 2014: $4.20 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: